Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for PRGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 1992. Start Trial.
Date Value
December 31, 2025 238.50M
December 31, 2024 362.90M
December 31, 2023 405.50M
December 31, 2022 307.30M
December 31, 2021 156.30M
December 31, 2020 636.20M
December 31, 2019 387.80M
December 31, 2018 593.00M
December 31, 2017 694.10M
December 31, 2016 654.90M
December 31, 2015 200.90M
June 30, 2014 693.50M
June 30, 2013 553.80M
June 30, 2012 513.38M
June 30, 2011 373.96M
June 30, 2010 314.17M
June 30, 2009 258.34M
Date Value
June 30, 2008 248.31M
June 30, 2007 128.92M
June 30, 2006 126.53M
June 30, 2005 65.07M
June 30, 2004 118.53M
June 30, 2003 80.23M
June 30, 2002 104.19M
June 30, 2001 68.22M
June 30, 2000 117.81M
June 30, 1999 -15.40M
June 30, 1998 22.34M
June 30, 1997 86.54M
June 30, 1996 72.92M
June 30, 1995 42.38M
June 30, 1994 60.73M
June 30, 1993 31.87M
June 30, 1992 19.15M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Avadel Pharmaceuticals Plc --
Jazz Pharmaceuticals Plc 1.356B
GH Research Plc -43.55M
Cosmo NV -13.02M
Viatris, Inc. 2.316B